Yamaguchi, Katsuya
Tomita, Ryo http://orcid.org/0000-0003-3935-9283
Koyanagi, Yoshito
Kawase, Kazuhide
Asaoka, Ryo
Terasaki, Hiroko
Iwase, Takeshi
Nishiguchi, Koji M.
Funding for this research was provided by:
Japan Society for the Promotion of Science (21K16870)
Article History
Received: 19 May 2023
Revised: 4 October 2023
Accepted: 23 October 2023
First Online: 3 November 2023
Declarations
:
: This study was conducted in adherence to the tenets of the Declaration of Helsinki. The procedures were approved by the Institutional Review Board and the Ethics Committee of the Nagoya University Graduate School of Medicine.
: The institutional review board exempted this study from informed consent due to the retrospective study design. We published the study protocol on the website and offered participants the opportunity to opt out.
: The Standards for Reporting of Diagnostic Accuracy Studies (STARD) checklist for this study is shown as a InternalRef removed [CitationRef removed].
: KY, None; RT, None; YK, None; KK received honoraria for lectures from Senju; RA, None; HT received non-financial research support from Carl Zeiss related to swept source optical coherence tomography and grants and honoraria for lectures from Otsuka, Kowa, Santen, Senju, Sanofi, Alcon, Novartis, ROHTO, and Wakamoto. She received grants and consulting fees from Bayer and honoraria for lectures from HOYA and Johnson & Johnson; TI, None; KN received grants from Takara bio, Takeda pharmaceutical, JCR Pharma, Alcon, and Bayer, and honoraria for lectures from Novartis, Santen, Chugai Pharma, Kowa, Senju, Otsuka, and Wakamoto. He has a patent related to a single AAV vector.